Alex Zhavoronkov
Insilico Medicine · UAE/USA
Composite score: 100.0
Rubric
benchmarks_authored
5/5
benchmark_citations
5/5
scope
5/5
community_role
5/5
recency
5/5
rigor_flags
5/5
Profile
Primary benchmarks
- MOSES — 72.4
- Longevity Benchmark (Insilico) — 90.6
- TargetBench (Insilico) — 84.6
- ClinBench Quarterly (Insilico) — 81.5
- ISM Benchmarks: GPCRs (Insilico) — 87.6
- ISM Benchmarks: ADMET (Insilico) — 84.6
Affiliated groups
Notes
Insilico Medicine founder/CEO. Longevity + AI drug discovery. Co-author MOSES. Drove ScienceAIBench/InsilicoBench/DDB.